Marja Pihlajamäki

Summary

Affiliation: University of Turku
Country: Finland

Publications

  1. ncbi Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents
    M Pihlajamaki
    National Public Health Institute, Antimicrobial Research Laboratory, Kiinanmyllynkatu 13, 20520 Turku, Finland
    Clin Infect Dis 33:483-8. 2001
  2. ncbi Ribosomal mutations in Streptococcus pneumoniae clinical isolates
    Marja Pihlajamäki
    Antimicrobial Research Laboratory, National Public Health Institute, Turku, Finland
    Antimicrob Agents Chemother 46:654-8. 2002
  3. ncbi Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000
    Marja Pihlajamäki
    Antimicrobial Research Laboratory, National Public Health Institute, Kiinamyllynkatu 13, 20520 Turku, Finland
    J Antimicrob Chemother 49:785-92. 2002
  4. ncbi Antimicrobial resistance of invasive pneumococci in Finland in 1999-2000
    Marja Pihlajamäki
    Antimicrobial Research Laboratory, National Public Health Institute, Turku, Finland
    Antimicrob Agents Chemother 47:1832-5. 2003
  5. ncbi Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001
    Miika Bergman
    National Public Health Institute, Antimicrobial Research Laboratory, Turku, Finland
    Clin Infect Dis 38:1251-6. 2004

Detail Information

Publications5

  1. ncbi Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents
    M Pihlajamaki
    National Public Health Institute, Antimicrobial Research Laboratory, Kiinanmyllynkatu 13, 20520 Turku, Finland
    Clin Infect Dis 33:483-8. 2001
    ....
  2. ncbi Ribosomal mutations in Streptococcus pneumoniae clinical isolates
    Marja Pihlajamäki
    Antimicrobial Research Laboratory, National Public Health Institute, Turku, Finland
    Antimicrob Agents Chemother 46:654-8. 2002
    ....
  3. ncbi Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000
    Marja Pihlajamäki
    Antimicrobial Research Laboratory, National Public Health Institute, Kiinamyllynkatu 13, 20520 Turku, Finland
    J Antimicrob Chemother 49:785-92. 2002
    ..The rise in erythromycin resistance is worrying, as macrolides are commonly used as first- and second-line drugs in pneumococcal infections...
  4. ncbi Antimicrobial resistance of invasive pneumococci in Finland in 1999-2000
    Marja Pihlajamäki
    Antimicrobial Research Laboratory, National Public Health Institute, Turku, Finland
    Antimicrob Agents Chemother 47:1832-5. 2003
    ..0% of isolates. Active macrolide efflux, mediated by the mef(A) gene, was the most common macrolide resistance mechanism. Four macrolide-resistant isolates had mutations in rRNA or ribosomal protein L22...
  5. ncbi Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001
    Miika Bergman
    National Public Health Institute, Antimicrobial Research Laboratory, Turku, Finland
    Clin Infect Dis 38:1251-6. 2004
    ..A statistically significant association existed between regional erythromycin resistance in S. pyogenes and consumption of macrolides; association with azithromycin use alone was not found...